Today’s Concerns About Drug Prices Echo The Past
Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.
Health Industry
2,001 - 2,020 of 3,924 Results
-
-
Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.
-
For 2020 Dem Hopefuls, ‘Medicare-For-All’ Is A Defining Issue, However They Define It
Support for “Medicare-for-all” is becoming a front-runner topic among Democratic presidential candidates. But the phrase is being used to describe any number of policies.
-
The High Cost Of Sex: Insurers Often Don’t Pay For Drugs To Treat Problems
Medicare and many private insurers view prescribing drugs to improve sexual function as a lifestyle issue that’s not medically necessary to pay for.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Glimpsing The Future At Gargantuan Health Tech Showcase
Innovations to help consumers manage their health were on display at the nation’s largest health technology conference that attracted more than 40,000 health industry professionals to Orlando.
-
Podcast: KHN’s ‘What The Health?’ ‘Medicare-For-All’ For Dummies
The “Medicare–for-all” debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner for a beginner’s guide to the next big health policy debate. For “extra credit,” the panelists provide their favorite health policy stories of the week, and as a special Valentine’s Day bonus, their favorite #HealthPolicyValentines.
-
Beyond Beltway’s ‘Medicare-For-All’ Talk, Democrats In States Push New Health Laws
As calls for "Medicare-for-all" grow louder among Democrats in Congress, Democratic governors and mayors have been pushing ahead with urgency to corral medical costs and bring health care to those who remain uninsured.
By Sarah Varney -
Can California Beat The Federal Government In Lowering Drug Prices?
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money — one he hopes other states can join.
-
A ‘Fountain Of Youth’ Pill? Sure, If You’re A Mouse.
The race for the cure to aging sparks hope and hype among top scientists — plus billions of dollars in investment.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Podcast: KHN’s ‘What The Health?’ A ‘Healthy’ State Of The Union
Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.
-
Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren’t For Sale
President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven’t reached the market.
By Sydney Lupkin and Jay Hancock -
Trump Highlights Health Agenda With Vow To Lower ‘Unfair’ Drug Prices
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
By Julie Rovner -
Ideas To Curb Surprise Medical Bills Percolate With Rare Bipartisan Push
The recent declaration by President Donald Trump that taming unexpected medical bills would be a top priority for his administration echoed through the halls of Congress.
By Shefali Luthra and Emmarie Huetteman -
Transparent Hospital Pricing Exposes Wild Fluctuation, Even Within Miles
A new federal rule requires hospitals to post their prices online. These lists reveal the wildly different charges for basic procedures and services, but consumers will have a hard time putting this information to use.
-
Task Force Outlines Strategy To Address California’s Shortfall Of Health Workers
A new report by a coalition of health, education and labor leaders concludes that the state must build a larger and more culturally diverse pool of medical, mental health and home care professionals to meet the needs of a growing population. The findings point to a big challenge for Gov. Gavin Newsom as he seeks to extend health insurance to many of California’s nearly 3 million uninsured residents.
By Anna Gorman -
Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals
The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.
By Jay Hancock -
Lawsuit Details How The Sackler Family Allegedly Built An OxyContin Fortune
WBUR and other media organizations sued Purdue Pharma to force the release of previously redacted information in a case brought by the Massachusetts attorney general.
-
Patients Suffer When Health Care Behemoths Quarrel Over Contracts
The latest example is Sutter Health and Anthem Blue Cross, whose failure to seal a deal is causing Anthem members to worry they may not have access to one of the dominant hospital chains in Northern California. Across the U.S., the stakes in such contract fights have risen, as health systems and insurers battle to increase their market share.